Medacta Growth Spurred by New Products and Expanded Salesforce

Medacta reported 1H21 orthopedic revenue of €177.5 million (USD $216.6 million), +31.7% vs. 1H20. The company's performance remains impressive even against its 1H19 comparison, as it grew +17.1% compared to that period. Medacta pointed to growth drivers including the faster-than-expected recovery of surgical volumes, continued innovation with...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us